{"@id":"https://bioecon.ru/technology/humanized-multi-organoid-co-culture-assays/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/humanized-multi-organoid-co-culture-assays/","json":"https://cn.bioecon.ru/api/v1/technology/humanized-multi-organoid-co-culture-assays/index.json"},"id":"humanized-multi-organoid-co-culture-assays","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/danagreen/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/botanical-solution-inc/","https://bioecon.ru/companies/kilimorgano/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/lidea-seeds/","https://bioecon.ru/companies/rev-genomics/","https://bioecon.ru/companies/caladan-bio/"]},"maturity":8,"name":"人源化多器官类器官共培养药物筛选评价体系","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"原代人源组织干细胞温和解离提取"},{"n":2,"title":"三维器官型水凝胶微孔阵列构建"},{"n":3,"title":"自体外周免疫细胞与基质成纤维共浸润"},{"n":4,"title":"高内涵多重表型与分泌组学连续监测"}],"summary":"整合原代人源组织类器官、自体免疫细胞及间质成纤维细胞的标准化三维共培养系统，在生理性细胞外基质微环境中高保真模拟多组织交互网络，用于精准评估抗肿瘤疗效、全身脏器毒性及细胞因子释放综合征风险。","url":"/technology/humanized-multi-organoid-co-culture-assays/","verified":"2026-11-22"}